A Recombinant Vaccine Effectively Induces C5a-Specific Neutralizing Antibodies and Prevents Arthritis

OBJECTIVES: To develop and validate a recombinant vaccine to attenuate inflammation in arthritis by sustained neutralization of the anaphylatoxin C5a. METHODS: We constructed and expressed fusion protein of C5a and maltose binding protein. Efficacy of specific C5a neutralization was tested using the...

Descripción completa

Detalles Bibliográficos
Autores principales: Nandakumar, Kutty Selva, Jansson, Åsa, Xu, Bingze, Rydell, Niclas, Blom, Anna M., Holmdahl, Rikard
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958150/
https://www.ncbi.nlm.nih.gov/pubmed/20975959
http://dx.doi.org/10.1371/journal.pone.0013511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958150/
https://www.ncbi.nlm.nih.gov/pubmed/20975959
http://dx.doi.org/10.1371/journal.pone.0013511

Ejemplares similares